Neo Kuma sees early success on psychedelic healthcare investments
Neo KUma Ventures, the UK’s first investment fund dedicated solely to psychedelic healthcare, is to invest in seven innovative healthcare companies.
Neo KUma Ventures, the UK’s first investment fund dedicated solely to psychedelic healthcare, is to invest in seven innovative healthcare companies.
Tunstall Healthcare (Tunstall), a UK-based, global provider of software solutions, services and technology for the telecare and telehealth markets, has acquired Secuvita BV (Secuvita), a technology solution provider in the Netherlands. The transaction will support Tunstall’s strategic expansion in digital solutions and services and strengthen its position in the Dutch
Kester Capital, a primary buyout specialist, has sold Frontier Medical Group to funds advised by Agilitas Private Equity, netting 3.4x and a 30 per cent IRR for its investors. This is the fourth exit from Kester’s last fund to have achieved a return of over 3.0x. This fund, which closed
Adenia Partners, a private equity firm investing in Africa, has completed the acquisition of Africa Biosystems Limited (ABL), a distributor of life sciences and clinical diagnostics equipment in East Africa. Financial terms of the deal have not been disclosed. Established in 1999, ABL is headquartered in Kenya with subsidiary offices
Mid market private equity firm MidOcean Partners (MidOcean) has sold its majority investment in The Planet Group (Planet), one of the world’s leading diversified professional services organisations. Planet will be merging with ProPharma Group (ProPharma), a portfolio company of Odyssey Investment Partners. Financial terms of the transaction were not disclosed.
Palamon Capital Partners (Palamon) has partnered with the management team of IDH Group (IDH) to enter into a binding share purchase agreement to acquire The Carlyle Group’s (Carlyle) shareholding and the shares held by the other minority shareholders in the Company to become the sole equity sponsor. The transaction is

Frazier Healthcare Partners has closed Frazier Healthcare Growth Buyout Fund X, its 10th healthcare private equity fund focused on the middle market, a vehicle which was oversubscribed and hit its USD1.4 billion hardcap. The capital came in from new as well as existing limited partners, including public pension funds, financial institutions,
MediSpend, a global technology company providing solutions for the life sciences industry, has secured a majority investment from Susquehanna Growth Equity (SGE), an entrepreneur-centric growth equity firm exclusively focused on software and information services companies. SGE’s prior investments across the broader healthcare vertical include Evive, HMP Global, iContracts, MMIT, ProviderTrust
The Riverside Company, a global private investor focused on the smaller end of the middle market, has signed a definitive agreement to sell Greenphire, a specialist in financial lifecycle management software for clinical trials, to Thoma Bravo, a software focused private equity firm. The pending transaction is expected to close
Medtanken, a leading primary care group in Western Sweden and a portfolio company of Procuritas Capital Investors VI (Procuritas), has successfully made its first step into the specialist care sector by acquiring Citysjukhuset. With its passion for building strong sustainable businesses through transformational growth, Procuritas is facilitating accelerated development and
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm